Key Takeaways Elevated inflation during the Biden administration, peaking at 9.1% in June 2022, significantly eroded the real value of household savings and outpaced wage growth for many American families....
Key Takeaways The Federal Open Market Committee (FOMC) is expected to maintain the federal funds rate at 5.25–5.50 per cent in its July 2025 meeting, citing sustained economic strength. Core...
Key Takeaways Novo Nordisk’s stock value plummeted by 26%, erasing approximately USD 100 billion in market capitalisation, after the company revised its 2025 sales and profit forecasts downward. The revision...
Key Takeaways Ongoing US-China trade talks in Stockholm are focused on extending a tariff truce set to expire in August 2025, a critical decision point for global markets. China’s trade...
Key Takeaways The potential imposition of US tariffs ranging from 20% to 25% on Indian imports poses a significant risk to bilateral trade and could impede India’s economic growth projections...
Key Takeaways AMD’s data centre segment grew 115% year-over-year in its second quarter of 2025, reaching USD 2.834 billion and signalling strong momentum in high-performance computing. Analyst consensus points to...
Sterling Infrastructure (NASDAQ: STRL) is poised for growth with a Buy rating and a 12-month target price of $320, reflecting a 21% upside. Specialising in high-growth areas like e-infrastructure and...
Revelling in resilience, PayPal positions itself strongly within the digital payments arena, boasting Q1 2025 revenue of $7.7 billion, marking a 9% year-over-year increase. As the company eyes a 20%...
BioNTech pivots from pandemic success with an €18B cash reserve towards an audacious oncology and infectious disease strategy, eyeing a potential 35% stock upside. Despite shrinking vaccine demand, the mRNA...
Ligand Pharmaceuticals, a low-risk player in the biotech space, shows promise with a 12-month target of $165, reflecting 15% upside. The firm's clever asset-light model yields high-margin revenues through royalties...
